Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: NMDA receptor regulation of nNOS phosphorylation and induction of neuron death.

Authors: Rameau, Gerald A; Chiu, Ling-Yu; Ziff, Edward B

Published In Neurobiol Aging, (2003 Dec)

Abstract: Stimulation of NMDA receptors activates neuronal nitric oxide synthase (nNOS) and the production of nitric oxide (NO). Dephosphorylation of nNOS increases nNOS enzymatic activity. We have examined the regulation of nNOS phosphorylation in rat cortical neurons following NMDA receptor activation. We show that nNOS is constitutively phosphorylated and that NMDA receptor activation decreases the level of nNOS phosphorylation by a mechanism that is blocked specifically by NMDA receptor antagonists and inhibitors of the Ca2+-regulated phosphatases calcineurin and PP1/PP2A. Using quantitative digital microscopy, we show that NMDA receptor activation induces the accumulation of nitrotyrosine, a measure of nNOS activity, and TdT-mediated fluorescein-dUTP nick end labeling (TUNEL) positivity, a measure of cell death. A calcineurin inhibitor blocked the increase in both TUNEL and nitrotyrosine positivity. Notably, TUNEL was increased in those neurons that were most strongly positive for nitrotyrosine. We conclude that NMDA receptor activation induces death of neurons by a cell autonomous pathway involving nNOS dephosphorylation by a calcineurin-dependent mechanism.

PubMed ID: 14643384 Exiting the NIEHS site

MeSH Terms: Animals; Apoptosis/drug effects; Apoptosis/physiology*; Calcineurin Inhibitors; Calcineurin/metabolism; Cells, Cultured; Enzyme Inhibitors/pharmacology; Excitatory Amino Acid Agonists/pharmacology; Excitatory Amino Acid Antagonists/pharmacology; In Situ Nick-End Labeling; Nerve Degeneration/enzymology*; Nerve Degeneration/physiopathology; Neurodegenerative Diseases/enzymology; Neurodegenerative Diseases/physiopathology; Neurons/drug effects; Neurons/enzymology*; Nitric Oxide Synthase Type I; Nitric Oxide Synthase/metabolism*; Phosphoprotein Phosphatases/antagonists & inhibitors; Phosphoprotein Phosphatases/metabolism; Phosphorylation/drug effects; Rats; Receptors, N-Methyl-D-Aspartate/drug effects; Receptors, N-Methyl-D-Aspartate/metabolism*; Tyrosine/analogs & derivatives*; Tyrosine/metabolism

to Top